Myonexus Therapeutics

Myonexus Therapeutics is a biotechnology company focused on gene therapies for rare diseases at the clinical stage. Building on the leading technology of Nationwide Children's Hospital in the field of muscular dystrophy gene therapy, Myonexus Therapeutics has developed the first treatment plans targeting Limb-Girdle Muscular Dystrophy (LGMD) types 2D, 2B, 2E, 2L, and 2C.